Asia Deal Watch: Huadong Licenses Two Cancer ADCs From Heidelberg Pharma

 
• By Vibha Ravi, Anju Ghangurde, Joseph Haas, and Ian Haydock
  
Asia Deal Watch
• Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deal Watch

More from Deals